OABI- Omniab, Inc.
Omniab, Inc. (OABI) has 6 insiders with recent SEC Form 4 filings, including 2 buys and 10 sells. OABI is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.38M | $9.80M | - | |
| Dir | 2.93M | $6.56M | - | |
| Other | 383.6K | $859.3K | - | |
| CFO | 259.4K | $581.1K | - | |
| Dir | 93.3K | $209.0K | - |
Activity
Buys and sells only
Transactions
10 filings · page 2
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2025 | Berkman Charles S81 | Chief Legal Officer | Sale+OE | 7,206 | $2.00 | $14,412.00 | -1.9% | -10.5% | -27.8% | |
| Apr 7, 2025 | Gustafson Kurt A81 | Executive VP, Finance And CFO | Sale+OE | 7,206 | $2.00 | $14,412.00 | -3.1% | -10.5% | -27.8% | |
| Apr 7, 2025 | Foehr Matthew W72 | President And CEO | Sale+OE | 19,382 | $2.00 | $38,764.00 | -0.5% | -10.5% | -27.8% | |
| Apr 1, 2025 | Gustafson Kurt A81 | Executive VP, Finance And CFO | Sale+OE | 11,963 | $2.37 | $28,352.31 | -5.2% | -23.7% | -31.6% | |
| Mar 21, 2025 | Higgins John L66 | Director | Buy | 4,000 | $2.28 | $9,120.00 | +0.1% | -37.2% | -30.8% | |
| Mar 20, 2025 | Higgins John L66 | Director | Buy | 125,750 | $2.35 | $295,512.50 | +4.8% | -27.3% | -22.9% | |
| Feb 19, 2025 | Gustafson Kurt A81 | Executive VP, Finance And CFO | Sale+OE | 7,255 | $3.67 | $26,625.85 | -3.4% | -58.0% | -53.4% | |
| Feb 19, 2025 | Foehr Matthew W72 | President And CEO | Sale+OE | 33,486 | $3.67 | $123,033.26 | -0.4% | -58.0% | -53.4% | |
| Feb 19, 2025 | Berkman Charles S81 | Chief Legal Officer | Sale+OE | 15,470 | $3.68 | $56,857.05 | -2.1% | -58.0% | -53.4% | |
| Jan 21, 2025 | Berkman Charles S81 | Chief Legal Officer | Sell | 25,489 | $3.24 | $82,584.36 | -6.9% | -43.2% | -37.6% |